Search Results - Laura C. Cappelli

Refine Results
  1. 1
    Gastrointestinal and Hepatic Disease in Rheumatoid Arthritis

    Gastrointestinal and Hepatic Disease in Rheumatoid Arthritis by Ethan Craig, Laura C. Cappelli

    Published 2017
    Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    The relationships between cancer and autoimmune rheumatic diseases

    The relationships between cancer and autoimmune rheumatic diseases by Laura C. Cappelli, Ami A. Shah

    Published 2020
    Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Cancer immunotherapy-induced rheumatic diseases emerge as new clinical entities

    Cancer immunotherapy-induced rheumatic diseases emerge as new clinical entities by Laura C. Cappelli, Ami A. Shah, Clifton O. Bingham

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Immune-Related Adverse Effects of Cancer Immunotherapy— Implications for Rheumatology

    Immune-Related Adverse Effects of Cancer Immunotherapy— Implications for Rheumatology by Laura C. Cappelli, Ami A. Shah, Clifton O. Bingham

    Published 2016
    Get full text
    Revisão
    Save to List
    Saved in:
  5. 5
    Rheumatic and Musculoskeletal Immune‐Related Adverse Events Due to Immune Checkpoint Inhibitors: A Systematic Review of the Literature

    Rheumatic and Musculoskeletal Immune‐Related Adverse Events Due to Immune Checkpoint Inhibitors: A Systematic Review of the Literature by Laura C. Cappelli, Anna Kristina Gutierrez, Clifton O. Bingham, Ami A. Shah

    Published 2016
    Get full text
    Revisão
    Save to List
    Saved in:
  6. 6
    Association of HLA-DRB1 shared epitope alleles and immune checkpoint inhibitor-induced inflammatory arthritis

    Association of HLA-DRB1 shared epitope alleles and immune checkpoint inhibitor-induced inflammatory arthritis by Laura C. Cappelli, M. Tevfik Dorak, Maria Bettinotti, Clifton O. Bingham, Ami A. Shah

    Published 2018
    Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Polymyalgia rheumatica-like syndrome from checkpoint inhibitor therapy: case series and systematic review of the literature

    Polymyalgia rheumatica-like syndrome from checkpoint inhibitor therapy: case series and systematic review of the literature by Cassandra Calabrese, Laura C. Cappelli, Marie Kostine, E. Kirchner, Tawnie Braaten, Leonard H. Calabrese

    Published 2019
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  8. 8
    Sonographic Findings in Inflammatory Arthritis Secondary to Immune Checkpoint Inhibition: A Case Series

    Sonographic Findings in Inflammatory Arthritis Secondary to Immune Checkpoint Inhibition: A Case Series by Jemima Albayda, Eric J. Dein, Ami A. Shah, Clifton O. Bingham, Laura C. Cappelli

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Immune checkpoint inhibitor–induced inflammatory arthritis as a model of autoimmune arthritis

    Immune checkpoint inhibitor–induced inflammatory arthritis as a model of autoimmune arthritis by Laura C. Cappelli, Mekha A. Thomas, Clifton O. Bingham, Ami A. Shah, Erika Darrah

    Published 2020
    Get full text
    Revisão
    Save to List
    Saved in:
  10. 10
    Corticosteroid-resistant immune-related adverse events: a systematic review

    Corticosteroid-resistant immune-related adverse events: a systematic review by Eveline Daetwyler, Till Wallrabenstein, David König, Laura C. Cappelli, Jarushka Naidoo, Alfred Zippelius, Heinz Läubli

    Published 2024
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  11. 11
    Checkpoint Inhibitor-Associated Arthritis: A Systematic Review of Case Reports and Case Series.

    Checkpoint Inhibitor-Associated Arthritis: A Systematic Review of Case Reports and Case Series. by Nilasha Ghosh, Michael D. Tiongson, Carolyn Stewart, Karmela K Chan, Bridget Jivanelli, Laura C. Cappelli, Anne R. Bass

    Published 2021
    Revisão
    Save to List
    Saved in:
  12. 12
    Checkpoint Inhibitor–Associated Arthritis

    Checkpoint Inhibitor–Associated Arthritis by Nilasha Ghosh, Michael D. Tiongson, Carolyn Stewart, Karmela K Chan, Bridget Jivanelli, Laura C. Cappelli, Anne R. Bass

    Published 2020
    Get full text
    Revisão
    Save to List
    Saved in:
  13. 13
    Clinical presentation of immune checkpoint inhibitor-induced inflammatory arthritis differs by immunotherapy regimen

    Clinical presentation of immune checkpoint inhibitor-induced inflammatory arthritis differs by immunotherapy regimen by Laura C. Cappelli, Julie R. Brahmer, Patrick M. Forde, Dung T. Le, Evan J. Lipson, Jarushka Naidoo, Lei Zheng, Clifton O. Bingham, Ami A. Shah

    Published 2018
    Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Immune-related adverse events with immune checkpoint inhibitors affecting the skeleton: a seminal case series

    Immune-related adverse events with immune checkpoint inhibitors affecting the skeleton: a seminal case series by Kendall F. Moseley, Jarushka Naidoo, Clifton O. Bingham, Michael A. Carducci, Patrick M. Forde, Geoffrey T. Gibney, Evan J. Lipson, Ami A. Shah, William H. Sharfman, Laura C. Cappelli

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Higher levels of VEGF-A and TNFα in patients with immune checkpoint inhibitor-induced inflammatory arthritis

    Higher levels of VEGF-A and TNFα in patients with immune checkpoint inhibitor-induced inflammatory arthritis by Elise Gray-Gaillard, Ami A. Shah, Clifton O. Bingham, Jennifer H. Elisseeff, Joseph C. Murray, Julie R. Brahmer, Patrick M. Forde, Valsamo Anagnostou, Jennifer S. Mammen, Laura C. Cappelli

    Published 2025
    Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Immune checkpoint inhibitor-induced inflammatory arthritis persists after immunotherapy cessation

    Immune checkpoint inhibitor-induced inflammatory arthritis persists after immunotherapy cessation by Tawnie Braaten, Julie R. Brahmer, Patrick M. Forde, Dung T. Le, Evan J. Lipson, Jarushka Naidoo, Megan D. Schollenberger, Lei Zheng, Clifton O. Bingham, Ami A. Shah, Laura C. Cappelli

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    2019 American College of Rheumatology Recommended Patient‐Reported Functional Status Assessment Measures in Rheumatoid Arthritis

    2019 American College of Rheumatology Recommended Patient‐Reported Functional Status Assessment Measures in Rheumatoid Arthritis by Claire Barber, JoAnn Zell, Jinoos Yazdany, Aileen M. Davis, Laura C. Cappelli, Linda Ehrlich‐Jones, Donna Everix, J. Carter Thorne, Victoria Bohm, Lisa G. Suter, Alex Limanni, Kaleb Michaud

    Published 2019
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  18. 18
    Inflammatory arthritis and sicca syndrome induced by nivolumab and ipilimumab

    Inflammatory arthritis and sicca syndrome induced by nivolumab and ipilimumab by Laura C. Cappelli, Anna Kristina Gutierrez, Alan N. Baer, Jemima Albayda, Rebecca Manno, Uzma Haque, Evan J. Lipson, Karen B. Bleich, Ami A. Shah, Jarushka Naidoo, Julie R. Brahmer, Dung T. Le, Clifton O. Bingham

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Sicca Syndrome Associated with Immune Checkpoint Inhibitor Therapy

    Sicca Syndrome Associated with Immune Checkpoint Inhibitor Therapy by Blake M. Warner, Alan N. Baer, Evan J. Lipson, Clint Allen, Christian S. Hinrichs, Arun Rajan, Eileen Pelayo, Margaret Beach, James L. Gulley, Ravi A. Madan, Josephine Feliciano, Margaret Grisius, Lauren Long, Astin S. Powers, David E. Kleiner, Laura C. Cappelli, Ilias Alevizos

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Postapproval Comparative Safety Study of Tofacitinib and Biological Disease‐Modifying Antirheumatic Drugs: 5‐Year Results from a United States–Based Rheumatoid Arthritis Registry

    Postapproval Comparative Safety Study of Tofacitinib and Biological Disease‐Modifying Antirheumatic Drugs: 5‐Year Results from a United States–Based Rheumatoid Arthritis Registry... by Joel M. Kremer, Clifton O. Bingham, Laura C. Cappelli, Jeffrey D. Greenberg, Ann Madsen, Jamie Geier, Jose L. Rivas, Alina M. Onofrei, Christine Barr, Dimitrios A. Pappas, Heather J. Litman, Kimberly J. Dandreo, Andrea Shapiro, Carol A. Connell, Arthur Kavanaugh

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: